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Abstract 
Pharmacokinetics behaviour of the antibacterial in food producing animals, provides information on the 
rates of absorption and elimination, half-life in plasma and tissue, elimination pathways and metabolism. 
The dose and the dosing interval of the antimicrobial can be justified by considering the 
pharmacokinetic/pharmacodynamic (PK/PD) relationship, if established, as well as the severity of the 
disease, whereas the number of administrations should be in line with the nature of the disease. The 
target population for therapy should be well defined and possible to identify under field conditions. 
Based on in vitro susceptibility data, and target animal PK data, an analysis for the PK/PD relationship 
may be used to support dose regimen selection and interpretation criteria for a clinical breakpoint. 
Therefore, for all antibacterials with systemic activity, the MIC data collected should be compared with 
the concentration of the compound at the relevant biophase following administration at the assumed 
therapeutic dose as recorded in the pharmacokinetic studies. Currently, the most frequently used 
parameters to express the PK/PD relationship are Cmax/MIC (maximum serum concentration/MIC), %T 
> MIC (fraction of time in which concentration exceeds MIC) and AUC/MIC (area under the inhibitory 
concentration– time curve/MIC). Furthermore, the pharmacokinetic parameters provide the first 
indication of the potential for persistent residues and the tissues in which they may occur. The 
information on residue depletion in food-producing animals, provides the data on which MRL 
recommendations will be based. A critical factor in the antibacterial medication of all food-producing 
animals is the mandatory withdrawal period, defined as the time during which drug must not be 
administered prior to the slaughter of the animal for consumption. The withdrawal period is an integral 
part of the regulatory authorities’ approval process and is designed to ensure that no significant drug 
residue is present in the animal at slaughter. Drug residues in food-producing animals should comply 
with the MRL values for their target tissues in the animal species. 
 
